Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity / (Deficit) (Tables)

v3.21.1
Shareholders' Equity / (Deficit) (Tables)
3 Months Ended
Mar. 31, 2021
Reconciliation of the Company's Beginning and Ending Balances in Shareholders' Equity / (Deficit)

The following tables present a reconciliation of the Company’s beginning and ending balances in shareholders’ equity / (deficit) for the three months ended March 31, 2021 and 2020:

 

 

Total

Shareholders'

Equity / (Deficit)

 

Shareholders' deficit at January 1, 2021

 

$

(50,559

)

Share-based compensation expense

 

 

281

 

Issuance of ordinary shares, net

 

 

68,156

 

Issuance of warrants for ordinary shares

 

 

6,199

 

Exercise of warrants for ordinary shares

 

 

14,257

 

Issuance of ordinary shares on conversion of exchangeable notes

 

 

92,104

 

Net loss

 

 

(98,921

)

Shareholders' equity at March 31, 2021

 

$

31,517

 

 

 

 

Total

Shareholders'

Deficit

 

Shareholders' deficit at January 1, 2020

 

$

(26,238

)

Share-based compensation expense

 

 

597

 

Net loss

 

 

(16,100

)

Shareholders' deficit at March 31, 2020

 

$

(41,741

)

Schedule of Financial Assets Measured at Fair Value

The following table presents information about the Company’s financial assets that were carried at fair value on a recurring basis on the condensed consolidated balance sheet as of March 31, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation inputs utilized to determine such fair value.

 

March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Short-term investments

 

$

33,868

 

 

 

33,868

 

 

 

 

 

 

 

Other asset – advance payment to supplier

 

 

3,224

 

 

 

 

 

 

 

 

 

3,224

 

Total

 

$

37,092

 

 

$

33,868

 

 

$

 

 

$

3,224

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Other asset – advance payment to supplier

 

$

3,357

 

 

$

 

 

$

 

 

$

3,357

 

Warrant  
Schedule of Financial Assets Measured at Fair Value

The Company has classified the warrants as equity in accordance with ASC 815. The fair value of the warrants was valued at issuance using the Black-Scholes option pricing model with the following assumptions: 

 

 

 

February 8, 2021

 

Volatility

 

 

120

%

Expected term in years

 

4.99

 

Dividend rate

 

 

0

%

Risk-free interest rate

 

 

0.48

%

Share price

 

$

1.54

 

Fair value of warrants issued

 

$

1.27

 

The Company has classified the warrants as equity in accordance with ASC 815. The fair value of the warrants was valued at issuance using the Black-Scholes option pricing model with the following assumptions: 

 

 

February 10, 2021

 

Volatility

 

 

120

%

Expected term in years

 

4.98

 

Dividend rate

 

 

0

%

Risk-free interest rate

 

 

0.46

%

Share price

 

$

2.73

 

Fair value of warrants issued

 

$

2.32

 

The Company has classified the warrants as equity in accordance with ASC 815. The fair value of the warrants was valued at issuance using the Black-Scholes option pricing model with the following assumptions:

 

 

February 12, 2021

 

Volatility

 

 

120

%

Expected term in years

 

4.99

 

Dividend rate

 

 

0

%

Risk-free interest rate

 

 

0.50

%

Share price

 

$

2.26

 

Fair value of warrants issued

 

$

1.84